{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T18:10:02Z","timestamp":1784225402827,"version":"3.55.0"},"reference-count":8,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","license":[{"start":{"date-parts":[[2022,10,12]],"date-time":"2022-10-12T00:00:00Z","timestamp":1665532800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2023,1]]},"abstract":"<jats:p>New pediatric and adult subacute sclerosing panencephalitis cases between 1996 and 2020 were reported based on an established UK registry with no evidence of under-ascertainment using a separate pediatric surveillance system. After 15 years with no pediatric UK-acquired cases, 3 cases arose from 2017 after increased measles. Modeling suggested this was in line with measles notifications, underreporting of laboratory-confirmed measles or increased subacute sclerosing panencephalitis risk.<\/jats:p>","DOI":"10.1097\/inf.0000000000003744","type":"journal-article","created":{"date-parts":[[2022,11,21]],"date-time":"2022-11-21T17:02:00Z","timestamp":1669050120000},"page":"82-84","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":17,"title":["A Re-emergence of Subacute Sclerosing Panencephalitis in the United Kingdom"],"prefix":"10.1097","volume":"42","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9840-8917","authenticated-orcid":false,"given":"Helen","family":"Campbell","sequence":"first","affiliation":[{"name":"Immunisation and Vaccine Preventable Disease Division, UK Health Security agency, London, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jamie","family":"Lopez Bernal","sequence":"additional","affiliation":[{"name":"Immunisation and Vaccine Preventable Disease Division, UK Health Security agency, London, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antoaneta","family":"Bukasa","sequence":"additional","affiliation":[{"name":"Immunisation and Vaccine Preventable Disease Division, UK Health Security agency, London, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nick","family":"Andrews","sequence":"additional","affiliation":[{"name":"Immunisation and Vaccine Preventable Disease Division, UK Health Security agency, London, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elaine","family":"Baker","sequence":"additional","affiliation":[{"name":"The PIND Research Group, Addenbrooke\u2019s Hospital, Cambridge, United Kingdom."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Polly","family":"Maunder","sequence":"additional","affiliation":[{"name":"The PIND Research Group, Addenbrooke\u2019s Hospital, Cambridge, United Kingdom."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne Marie","family":"Winstone","sequence":"additional","affiliation":[{"name":"The PIND Research Group, Addenbrooke\u2019s Hospital, Cambridge, United Kingdom."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary","family":"Ramsay","sequence":"additional","affiliation":[{"name":"Immunisation and Vaccine Preventable Disease Division, UK Health Security agency, London, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher","family":"Verity","sequence":"additional","affiliation":[{"name":"The PIND Research Group, Addenbrooke\u2019s Hospital, Cambridge, United Kingdom."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin","family":"Brown","sequence":"additional","affiliation":[{"name":"Immunisation and Vaccine Preventable Disease Division, UK Health Security agency, London, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2022,10,12]]},"reference":[{"key":"R1-20260716","doi-asserted-by":"crossref","first-page":"1334","DOI":"10.1093\/ije\/dym207","article-title":"Review of the effect of measles vaccination on the epidemiology of SSPE.","volume":"36","author":"Campbell","year":"2007","journal-title":"Int J Epidemiol"},{"key":"R3-20260716","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1136\/adc.2003.038489","article-title":"The epidemiology of subacute sclerosing panencephalitis in England and Wales 1990\u20132002.","volume":"89","author":"Miller","year":"2004","journal-title":"Arch Dis Child"},{"key":"R4-20260716","doi-asserted-by":"crossref","first-page":"e689091","DOI":"10.1371\/journal.pone.0068909","article-title":"Epidemiology of subacute sclerosing panencephalitis (SSPE) in Germany from 2003 to 2009: a risk estimation.","volume":"8","author":"Schonberger","year":"2013","journal-title":"PLoS One"},{"key":"R5-20260716","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1093\/cid\/cix302","article-title":"Subacute sclerosing panencephalitis: the devastating measles complication that might be more common than previously estimated.","volume":"65","author":"Wendorf","year":"2017","journal-title":"Clin Infect Dis"},{"key":"R9-20260716","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1136\/adc.2009.173419","article-title":"The epidemiology of progressive intellectual and neurological deterioration in childhood.","volume":"95","author":"Verity","year":"2010","journal-title":"Arch Dis Child"},{"key":"R10-20260716","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.ejpn.2021.07.006","article-title":"A recent surge of fulminant and early onset subacute sclerosing panencephalitis (SSPE) in the United Kingdom: an emergence in a time of measles.","author":"Lam","year":"2021","journal-title":"Eur J Paediatr Neurol"},{"key":"R11-20260716","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.pneurobio.2009.12.003","article-title":"Emergence and re-emergence of viral diseases of the central nervous system.","volume":"91","author":"Griffin","year":"2010","journal-title":"Prog Neurobiol"},{"key":"R12-20260716","doi-asserted-by":"crossref","first-page":"769837","DOI":"10.1155\/2015\/769837","article-title":"Measles virus: identification in the M protein primary sequence of a potential molecular marker for subacute sclerosing panencephalitis.","volume":"2015","author":"Kweder","year":"2015","journal-title":"Adv Virol"}],"container-title":["Pediatric Infectious Disease Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/INF.0000000000003744","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T18:02:16Z","timestamp":1784224936000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/INF.0000000000003744"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10,12]]},"references-count":8,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2023]]}},"URL":"https:\/\/doi.org\/10.1097\/inf.0000000000003744","relation":{},"ISSN":["0891-3668"],"issn-type":[{"value":"0891-3668","type":"print"}],"subject":[],"published":{"date-parts":[[2022,10,12]]}}}